SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-188452"
 

Search: onr:"swepub:oai:DiVA.org:liu-188452" > Effect of N-3 Polyu...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Hande, Liv NesseNordland Hosp, Norway; UiT Arctic Univ Norway, Norway (author)

Effect of N-3 Polyunsaturated Fatty Acids on Lipid Composition in Familial Hypercholesterolemia : A Randomized Crossover Trial

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-07-27
  • MDPI,2022
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-188452
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-188452URI
  • https://doi.org/10.3390/biomedicines10081809DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Northern Norway Regional Health Authority (Helse Nord RHF) [SFP1311-16]; UiT The Arctic University of Norway
  • Individuals with familial hypercholesterolemia (FH) have an increased risk of cardiovascular disease. Treatment is mainly low-density lipoprotein cholesterol (LDL-C) reduction. How omega-3 polyunsaturated fatty acids (n-3 PUFAs) supplements affect lipoproteins in FH subjects is unknown. We hypothesized that a high-dose n-3 PUFA supplement would reduce atherogenic lipoproteins and influence the high-density lipoprotein cholesterol (HDL-C) function. We performed a randomized, double-blinded crossover study with 34 genetically verified FH individuals (18-75 years, clinically stable, statin treatment > 12 months). Treatment was 4 g n-3 PUFAs (1840 mg eicosapentaenoic acid and 1520 mg docosahexaenoic acid daily) or four capsules of olive oil for three months in a crossover design with a washout period of three months. The defined outcomes were changes in triglycerides, lipoproteins, lipoprotein subfractions, apolipoproteins, and HDL-C function. After treatment with n-3 PUFAs, total cholesterol, LDL-C, and triglycerides were reduced compared to placebo (p <= 0.01 for all). Total HDL-C levels were unchanged, but the subfraction of large HDL-C was higher (p <= 0.0001) after n-3 PUFAs than after placebo, and intermediate HDL-C and small HDL-C were reduced after n-3 PUFAs compared to placebo (p = 0.02 and p <= 0.001, respectively). No changes were found in apolipoproteins and HDL-C function. N-3 PUFAs supplements reduced atherogenic lipoproteins in FH subjects, leaving HDL-C function unaffected.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Kjellmo, ChristianNordland Hosp, Norway; UiT Arctic Univ Norway, Norway (author)
  • Pettersen, KristinNordland Hosp, Norway (author)
  • Ljunggren, StefanLinköpings universitet,Avdelningen för prevention, rehabilitering och nära vård,Medicinska fakulteten,Region Östergötland, Arbets- och miljömedicin(Swepub:liu)stelj68 (author)
  • Karlsson, HelenLinköpings universitet,Avdelningen för prevention, rehabilitering och nära vård,Medicinska fakulteten,Region Östergötland, Arbets- och miljömedicin(Swepub:liu)helka90 (author)
  • Cederbrant, KarinLinköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten(Swepub:liu)karce90 (author)
  • Marcusson-Ståhl, MarithaSwedish Toxicol Sci Res Ctr, Sweden (author)
  • Hovland, AndersNordland Hosp, Norway; UiT Arctic Univ Norway, Norway (author)
  • Lappegard, Knut ToreNordland Hosp, Norway; UiT Arctic Univ Norway, Norway (author)
  • Nordland Hosp, Norway; UiT Arctic Univ Norway, NorwayNordland Hosp, Norway (creator_code:org_t)

Related titles

  • In:Biomedicines: MDPI10:82227-9059

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view